Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film‐coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease
Varela‐Fascinetto, G., Benchimol, C., Reyes‐Acevedo, R., Genevray, M., Bradley, D., Ives, J., Silva, H. T.
Published in Pediatric transplantation (01.02.2017)
Published in Pediatric transplantation (01.02.2017)
Get full text
Journal Article
Tolerability of up to 200ￂ days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease
Varela-Fascinetto, G, Benchimol, C, Reyes-Acevedo, R, Genevray, M, Bradley, D, Ives, J, Silva, H T
Published in Pediatric transplantation (01.02.2017)
Published in Pediatric transplantation (01.02.2017)
Get full text
Journal Article
Les neuropathies anti-MAG : des neuropathies par hypersensibilité à la pression ?
Genevray, M., Nicolas, G., Letorunel, F., Pautot, V., Cassereau, J.
Published in Revue neurologique (01.04.2014)
Published in Revue neurologique (01.04.2014)
Get full text
Journal Article
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial
Davies, Andrew, Merli, Francesco, Mihaljević, Biljana, Mercadal, Santiago, Siritanaratkul, Noppadol, Solal-Céligny, Philippe, Boehnke, Axel, Berge, Claude, Genevray, Magali, Zharkov, Artem, Dixon, Mark, Brewster, Michael, Barrett, Martin, MacDonald, David
Published in The Lancet. Haematology (01.06.2017)
Published in The Lancet. Haematology (01.06.2017)
Get more information
Journal Article
Bioequivalence study of fluoxetine hydrochloride in healthy volunteers
Keller, Thomas, Cambon, Nathalie, Genevray, Magali, Crivelli, Fabrizio, Crivelli, Monia, Dal, Bo Lorenzo, Mazzucchelli, Paolo, Ismaili, Shevqet, Marzo, Antonio
Published in Arzneimittel-Forschung (01.01.2005)
Published in Arzneimittel-Forschung (01.01.2005)
Get more information
Journal Article